Gilead bets on Xilio cancer drug as biotech restructures
Sanders blasts Novo Nordisk for ‘outrageous’ price of Ozempic, Wegovy
J&J can contest evidence linking its talc to cancer, US judge rules
Boundless Bio breaks IPO lull with $100M fundraise
*please scroll down for all the latest news*
